Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Long-Term Deferred Tax (2022 - 2024)

Historic Long-Term Deferred Tax for ProQR Therapeutics (PRQR) over the last 3 years, with Q4 2024 value amounting to $3.5 million.

  • ProQR Therapeutics' Long-Term Deferred Tax fell 1873.13% to $3.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.5 million, marking a year-over-year decrease of 1873.13%. This contributed to the annual value of $3.5 million for FY2024, which is 1812.57% down from last year.
  • ProQR Therapeutics' Long-Term Deferred Tax amounted to $3.5 million in Q4 2024, which was down 1873.13% from $4.3 million recorded in Q4 2023.
  • In the past 5 years, ProQR Therapeutics' Long-Term Deferred Tax ranged from a high of $4.3 million in Q4 2023 and a low of $3.5 million during Q4 2024
  • For the 3-year period, ProQR Therapeutics' Long-Term Deferred Tax averaged around $3.9 million, with its median value being $4.0 million (2022).
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first surged by 712.59% in 2023, then tumbled by 1873.13% in 2024.
  • Over the past 3 years, ProQR Therapeutics' Long-Term Deferred Tax (Quarter) stood at $4.0 million in 2022, then grew by 7.13% to $4.3 million in 2023, then fell by 18.73% to $3.5 million in 2024.
  • Its last three reported values are $3.5 million in Q4 2024, $4.3 million for Q4 2023, and $4.0 million during Q4 2022.